Health Care & Life Sciences » Pharmaceuticals | Auris Medical Holding AG

Auris Medical Holding AG | Ownership

Companies that own Auris Medical Holding AG

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Rosalind Advisors, Inc.
2,050,489
8.52%
2,050,489
9.16%
07/25/2018
Sabby Capital LLC
263,625
1.1%
-79,364
0.04%
06/30/2018
Morgan Stanley & Co. LLC
260,286
1.08%
-265,497
0%
07/31/2018
Bellevue Asset Management AG
193,125
0.8%
-23,838
0%
06/30/2018
Wedbush Securities, Inc. (Investment Management)
63,290
0.26%
42,860
0%
06/30/2018
A.R.T. Advisors LLC
19,519
0.08%
19,519
0%
06/30/2018
Geode Capital Management LLC
18,206
0.08%
18,206
0%
06/30/2018
UBS Securities LLC
12,259
0.05%
10,757
0%
06/30/2018
Herculis Partners SA
6,000
0.03%
0
0.01%
07/31/2018
Morgan Stanley Smith Barney LLC (Private Banking)
1,040
0%
1,000
0%
06/30/2018

About Auris Medical Holding

View Profile
Address
Clarendon House
Hamilton HC HM 11
Bermuda
Employees -
Website http://www.aurismedical.com
Updated 07/08/2019
Auris Medical Holding AG engages in the provision of biopharmaceutical business. It focuses on the development of novel products for the treatment of inner ear disorders. It includes tinnitus, haring loss, and meniere's disease.